上海医药：2025年前三季度归属于上市公司股东的净利润同比增长26.96%

Core Insights - Shanghai Pharmaceuticals reported a revenue of 215,072,230,363.46 yuan for the first three quarters of 2025, representing a year-on-year growth of 2.60% [2] - The net profit attributable to shareholders of the listed company reached 5,147,064,933.11 yuan, showing a significant year-on-year increase of 26.96% [2] Financial Performance - Revenue for the first three quarters of 2025: 215.07 billion yuan, up 2.60% year-on-year [2] - Net profit for the same period: 5.15 billion yuan, up 26.96% year-on-year [2]